Japan Cabinet Agrees To Buy Foreign H1N1 Vaccine For 50 Million People
This article was originally published in PharmAsia News
Executive SummaryJapanese authorities at the highest level signed off on an H1N1 vaccination plan that calls for importing enough drugs to inoculate up to 50 million people in addition to the 27 million to be given locally made vaccines
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.